Dear Friend:
For two long years I've been watching this company like a hawk. I've analyzed every move in excruciating detail because the stakes are so high.
The tension was almost unbearable. That's because it was so incredibly close to a major diabetes breakthrough, I could easily envision this stock soaring like nothing else I have ever found in my entire investing career.
But 'close' isn't good enough.
I was waiting for the final piece of information to fall into place. This would give it full and exclusive access to breakthrough diabetes research that can make medical history. Finally, it happened.
Two years' worth of waiting has paid off beyond my wildest dreams. And I'm going to tell you all about it in this letter.
Hello, my name is Steven Lord and I'm editor of Trend Investor. Perhaps you've heard of me.
I was the editor of Steven Leeb's Emerging Investments. I was also a key contributor to his flagship publication, The Complete Investor.
After seeing the success of my stock selections and at the urging of my loyal readers, I decided it was time to put my name on the door, so I started my own publication.
If there's one thing I've discovered after more than 18 years of successful investing, it's this: there's always a unique opportunity somewhere to make an absolute killing. Here's how I routinely find these investments:
I identify which companies will benefit from long-term, strategic trends in the economy and then find the best stocks within the trend. My most successful investments precisely fit into these criteria.
Time magazine calls diabetes
'an epidemic.'
'It's one of the most exciting
stocks I've ever found!"
- Steven Lord
Editor, Steven Lord's Trend Investor |
|
These stocks always have a sustainable, protected advantage over competitors in a growth market of major importance. And they're not easy to find. If you locate two of them over a 15-year period, you're doing exceptionally well.
And it's why this company is so exciting... it has everything.
Rarely am I this enthusiastic. I'm a cautious person by nature, but I'm not hesitant to start waving the green flag when I see all the elements present that make a great investment great. And they're here in spades.
This story is so compelling and the amount of money you can make is so enormous, I've just finished a non-stop marathon session at my computer putting the finishing touches on a landmark Report that describes this company in detail.
And with your permission, I will send you a free copy.
This is the first opportunity for the public to read its contents. It's the result of my two long years of following and analyzing every move these folks made.
I promise you that it brings you breaking news and fresh analysis you cannot find anywhere else. I guarantee that. I'll tell you more about my guarantee later, but before you make an investment, this is precisely what you have to know.
I can't urge you enough to get your free copy...
The Amount of Money to Be Made
in Healthcare Is Staggering
Successful healthcare stocks can literally make you a millionaire in a very short period of time. They return spectacular gains because Wall Street values them so highly.
The investing community knows that an effective medical remedy is like having a license to print money -- it's that profitable. Plus, America is an aging nation. We have 79 million baby boomers heading toward retirement. They're going to require more healthcare, not less. Here's proof on how high a successful healthcare stock can go.
- Up 59 TIMES . From 59 cents to $36. MedImmune turned $5,000 into $300,000.
- Up 24 TIMES . From $2 to $50. Healthways delivered on its promise and went up 24 times, turning $5,000 into $125,000.
- UP 58 TIMES . From $1.07 to $64. Amgen made numerous breakthroughs. So did its stock, turning $5,000 into $299,050.
- UP 10.2 TIMES . From $4 to $45. Teva was a complete unknown that fooled its critics, turning $5,000 into $56,000.
- UP 15.2 TIMES . From $3.63 to $59. Medtronic scored a bull's-eye by transforming $5,000 into $125,000.
- UP 20 TIMES . $3.70 to $80.10. Guidant exceeded all expectations, turning $5,000 into $108,200.
- UP 15 TIMES . From $4 to $65. Sepracor handed investors a remarkable gain, turning $5,000 into $81,250.
- UP 25 TIMES . From $3.83 to $100. Everyone knows Genentech. It turned $5,000 into $130,500.
I'm Easily Talking About Possible Profits Like These...
If you're a serious investor, my favorite stock should be in your portfolio. That's because I believe that this company could match the gains you've just read.
The key to understanding the investment opportunity here is to realize the immense challenge diabetes now presents... and even more importantly, the coming catastrophic impact of this illness. Most people don't have a clue.
It matches my investment criteria perfectly: capturing the big, long-term trends that are virtually irreversible -- and then selecting the company that's best positioned to grab the biggest share.
Diabetes is that trend. There's not a single doubt about it. Consider this appalling fact...
The American Diabetes Association is a conservative, respected organization -- and they're talking about 62 million deaths. Let's put this figure in perspective:
- The Korean War lead to the death of 54,200 American soldiers...
- WW I saw 53,100 soldiers lose their lives...
- WW II had 407,000 soldier fatalities...
- The Vietnam War reported 58,200 soldier deaths.
'Medimmune went from 59 cents to $36 -- up 59 times.'
Prevention magazine says:
'Diabetes has become
a full-blown epidemic.' |
|
This total comes to 572,500 deaths in our military. A tragic figure. Now compare it to what diabetes can do to us: 62 million people die. That's 108 times GREATER than all the people we lost in these four wars. It's absolutely astonishing. The American Diabetes Association is not alone...
THE NEW YORK TIMES Reports, 'The diabetes epidemic will overwhelm health care resources everywhere if governments do not wake up and take action...'
'Either we fall apart or we stop this,' says Dr. Thomas R. Frieden, commissioner of the New York City Department of Health and Mental Hygiene. He's not alone.
- USA TODAY Warns 73 Million Are at Risk in America: 'A study says that 73 million Americans have diabetes or are at risk... there's a tremendous problem in this country with diabetes -- it represents a genuine epidemic.'
- TIME Magazine Ran a Shocking Cover Story on Diabetes: It was entitled, 'Why Are So Many of Us Getting Diabetes?' It says it's 'an epidemic that keeps on raging,' then adding, 'what alarms public health experts the most is the speed at which diabetes has spread...'
This is why a cure or even a near-cure for diabetes could carry its stock high into the stratosphere. Its remedy could easily become one of the best-selling drugs in the world. And it would be the only one selling it. That's why early investors in this stock can be rewarded beyond their fondest dreams.
A Brilliant Way to Fight Diabetes --
Many Call It a Breakthrough
Let me first share its clever strategy for making this happen. I've been on Wall Street long enough to realize that when I hear the word 'cure,' it's always associated with a high level of risk.
Nothing interests me more than finding a grand-slam stock that lets me retire a decade earlier than I planned... but I'm definitely NOT going to take senseless risks with my hard-earned money. That's precisely why I'm so excited about this company.
It's come up with an ingenious strategy to conquer diabetes in a way that lets me sleep like a baby at night. To understand what it has done, you have to know the following fact...
The greatest medical breakthroughs are coming from the small biotech/research companies -- and I still wouldn't buy them. That's because they're often 'one-product' companies that live or die on the success of their research.
If they manage to create something worthwhile and get FDA approval, the sky's the limit. But if what they're working on doesn't succeed, the stock can go down. My favorite company solves this problem.
A Long History of Generating Unending
Wealth for Their Stockholders
The company I'm talking about offers us the safety of an established, highly profitable enterprise with $4.3 billion dollars in the bank -- which it has -- along with the astounding profit potential of the top five biotech/research companies that are zeroing in on the solution that can break the back of diabetes.
It's doing this by entering into ironclad research agreements that gives it exclusive rights to the breakthrough solutions of these extraordinary biotech research enterprises.
In return, my favorite company finances the research that it can easily afford with $4.3 billion in the bank and record profits rolling in every month.
I Have a Free Report on This
Breakthrough Diabetes Stock.
Get your free copy by clicking the subscribe button at the end of this letter
Dr. Mercola reports:
'Diabetes is out of control.' |
|
My company has the funds for extensive research, the worldwide pipeline spanning 124 countries for product distribution, the recognizable name to open doors and the priceless know-how of marketing drugs effectively.
Innovation and discovery are nothing new to this legacy stock. It has a long, respected history of treating its shareholders very well. It's not a name that appears in the headlines every day to garner publicity. Individuals who invested in this remarkable company almost always stay shareholders. It's that good.
At the end of the day, you and I get the profit potential of these research super stars AND the protection of a major drug enterprise with a long history of highly successful product introductions. Everyone wins.
I've never been more excited about a stock that could return 9 to 14 times your money -- or much more.
You could search for the next 16 years and not find a stock with such an eye-opening, wealth-making opportunity. That's why I was content to wait two long years before it all came together.
I knew it was worth every single second.
Want another bonus? It pays a 3% or so dividend. No, I'm not saying that you should buy it to earn 3% on your money. Far from it. What I like is that you get paid while waiting for it to hand you a tenfold gain, or potentially much, much more.
I mentioned the coming catastrophe diabetes is going to inflict on America and virtually every other country in the world. Let me give some additional facts. They're important to provide you with a sense of the IMMENSE demand for a remedy that helps to stop diabetes.
I've Never Read Anything So Terrifying as This...
We talk about protecting our country -- and I'm all for that -- but it also should include protecting up to 73 million Americans at risk. That's the number USA TODAY reported, quoting a respected study. Also consider...
- THE NEW YORK TIMES Confirms the Coming Disaster : 'Doctors fear a huge wave of new cases could overwhelm the public health system and engulf growing numbers -- where hospitals are swamped. Its awful toll quietly emerges as a crisis. It's frightening.'
- Tommy G. Thompson, Health and Human Services Secretary in the federal government says, 'Diabetes has reached epidemic proportions and it's still on the rise.'
- Dr. Robert Rizzo, a Professor at the World Famous MAYO CLINIC: 'We've got to stop this. There has been a tremendous concern, but probably not enough concern about the emerging epidemic of diabetes.'
- WebMD Says : 'New cases of type 2 diabetes are rising dramatically among U.S. adults...'
- FORBES Magazine calls it a disaster : It states, 'This trend must be reversed to avoid serious repercussions to the healthcare system and the U.S. economy.'
- THE ROYAL GAZETTE says it kills like AIDS: ''Diabetes now claims as many lives as HIV/AIDS, according to The International Diabetes Federation.'
The world is just now waking up to the mind-boggling disaster at hand -- and the urgent need to finally do something about it.
Do You Know What Diabetes Really Is?
Here's an Excellent Description
From THE NEW YORK TIMES
I know that you've heard of diabetes, and I'm almost certain that you know someone right now with it. But do you know what it really is? Here's how THE NEW YORK TIMES accurately describes it.
'Healthways soared from $2 to $50 -- up 24 times.'
Dr. Weil says:
'Diabetes is becoming
increasingly prevalent.' |
|
'Simply put, diabetes is a condition in which the body has trouble turning food into energy. All bodies break down digested food into a sugar called glucose, their main source of fuel. In a healthy person, the hormone insulin helps glucose enter the cells. But in a diabetic, the pancreas fail to produce enough insulin.
'Cells starve while the glucose builds up in the blood. There are two types of diabetes. In Type 1, the immune system destroys the cells in the pancreas that make insulin. In Type 2, which accounts for 90% to 95% of all cases, the body's cells are not sufficiently receptive to insulin, or the pancreas makes too little of it.'
The problem is not just those with diabetes. Millions of people either don't know that they have diabetes -- or else they have something called 'pre-diabetes.' This is the stage before you get the full-blown illness.
Diabetes Has a 'Dirty Little Secret.'
It's Why the Pressure to Stop It Is Growing Like Crazy.
And It's Why We Can Shovel in Profits Hand Over Fist
After what you've just read -- the experts talking about what a catastrophe diabetes is, that's not the whole picture. It gets worse.
Life Extension
Foundation says:
'The number of people with diabetes will reach 300 million -- a staggering 122% increase.'
'You could retire 10 to 15 years earlier on your profit.'
- Steven Lord
Editor, Steven Lord's Trend Investor
|
|
It's hard to imagine how that's possible -- but it is. For this I turn to an article in the ORLANDO SENTINEL. It reported on the meeting of the highly respected American Diabetes Association.
In it, it talked about the other major illness diabetes is now believed to lead to. So it's not just what diabetes itself does, it's what it can cause. This is what it revealed...
'The numbers are staggering: 35 million heart attacks, 13 million strokes, 2 million amputations and 62 million deaths. That's the expected toll from diabetes... unless major action is taken to curb and control it.' The article then says that 'this will cost the U.S. economy $6.6 trillion dollars.' But this is what scares me the most.
Alzheimer's. This condition alone is a major health challenge. Now to think that diabetes may spark it in some deep, still unknown way is a terrifying idea.
THE CONTRA COSTAL TIMES reported on this saying, 'A provocative new theory suggests that one root cause of Alzheimer's is linked to diabetes. It's a scary scenario: Alzheimer's is expected to skyrocket as the population gets older, rising from 4.5 million to 14 million...'
I'm Not Telling You This to Scare You, But to
Show You the IMMENSE Demand There Is Going to
Be for a Remedy to Diabetes. It's off the charts...
Let's catch our breath for a second and sum things up. Think of what you've just read about the number of people who will get diabetes and the far-reaching impact it's going to have.
Now ask yourself this question: what would individuals pay -- or even governments pay -- to avoid all this? My answer is this: anything. Wouldn't you? Patients by the millions will demand the life-saving solutions my favorite company has developed.
What's the alternative? Suffer with the illness? WebMD got it right when they said, 'You have diabetes and you want it cured.'
This Opportunity Blows the Doors
off Any Investment I've Ever Seen
Imagine the enviable spot this company can be in. First, it has a solution to a problem that everyone acknowledges is an extraordinary threat -- the big trend idea. Second, it's protected against competition by an army of high-power patents -- the sustainable profit idea.
The Mayo Clinic warns:
'We've got to stop this.'
National Institutes of Health:
'Diabetes can lead to serious problems. The most serious problem is heart disease.' |
|
That, dear reader, is the definition of a great investment. The flood of cash that can generate is beyond belief. My years spent following this company will be richly rewarded. You should consider immediately adding it to your portfolio.
Please remember that I've just finished a free Report entitled Grow Rich in This 'Medical Miracle' Super Stock that brings you the complete picture on this company. It's just published and I'll rush you a copy.
I've been actively writing and researching in the financial field for over 18 years and I've never run across anything quite like it.
Please don't let time slip away. Get your free Report now by subscribing for a risk-free trial to Steven Lord's Trend Investor.
A Secret Hidden in Nature --
Discovered by Top Researchers
Finding the secret was a stroke of true genius. It began with a sharp-eyed, brilliant scientist who thought, 'there might be something here.' He was on the verge of a discovery that can rival penicillin.
To better understand this, you have to remember this one fact. When someone has diabetes, their pancreas does not produce enough insulin. Insulin is used by your body to turn glucose (also known as blood sugar) into energy.
When there's a shortage of insulin, glucose dangerously builds up and gets out of control. That's a genuine life-threatening development.
Scientists have found an all-natural chemical that allows the pancreas of a diabetic to automatically produce MORE insulin, while increasing the length of time the insulin stays in their bloodstream.
This greatly reduces the life-threatening level of glucose that builds up in the bloodstream. It's a 'smart' remedy in the sense that when you have a problem, it detects this and helps you. This is a HUGE breakthrough.
My Jaw Dropped When I Found Out
Where This 'Miracle Worker' Came From
This phenomenal all-natural chemical comes from a reclusive, little-known animal in the southwestern section of the United States that eats perhaps six times a year.
'I've never been more enthusiastic about a stock.
This one could make you rich. You'll deeply regret it if you miss this one. Don't be left behind!' '
- Steven Lord
Editor, Steven Lord's Trend Investor
|
|
There was a substance in this animal that resembled a chemical in people that allowed healthy humans to control the level of sugar in their bodies. Scientists began to wonder if there was a link between the two.
Would it be possible to somehow change this substance so that it would help diabetics gain control over their blood sugar levels once again -- the way we all do?
After years of research and the expenditure of many millions of dollars, they knew they had a breakthrough. Not only does it help diabetics regulate their blood sugar levels, it only goes to work when it senses a high blood sugar level.
I Am Predicting That When Medical History
Is Written, This Discovery Will Rank
Alongside the Discovery of Penicillin
How can it not? Remember, the conservative American Diabetes Association is talking about 62 million people potentially dying from this disease. It's one of the greatest challenges our nation faces.
Also remember that the death toll from the Korean War, WWI, WWII and the Vietnam War came to 572,500 American soldiers. The toll from diabetes could be 108 times greater than all four of these wars combined. That has to be the most upsetting and least-known statistic I've EVER read.
Please Request Your Free Report Immediately.
It's New and I've Already Received a Flood of
Requests From Investors All Across America
I've never felt more confident about the future of a stock. I say that being a cautious investor with many years of experience. That's why I urge you to buy this stock now. This opportunity will NOT last forever. Rarely do all the stars in the sky line up like they are here.
'Amgen rose from $1.07 to $64 -- up 58 times.
$10,000 soared to $590,000.'
|
|
I'm talking about the immense size of the market, its proprietary solution, the almost unending demand for it, both nationally and internationally, and the army of patents that will protect it for many years to come. This stock can blow the barn doors off of it. The industry is phenomenal. It's the most reliable way to get rich.
It's why I'm confident in telling you this one stock could return 9 - 14 times your money... and probably much more!
59 Cents to $36. $2 to $50.
You Don't Need Many Stocks to Retire Early
Wall Street knows how extremely profitable this can be. That's precisely why these stocks go up like you can't believe at even the slightest hint of success. Look at MedImmune. It went from 59 cents to $36. $10,000 in this one became worth $600,000. Healthways was another. It soared from $2 to $50. $10,000 in that one turned into $250,000.
Teva was unknown at $4. When it hit $45, it was big news. Medtronic is well known today. But at $3.63 a share it was a stunning buy. It later hit $59. That turns $10,000 into a welcomed $162,000. Sepracor rose from $4 to $65, sending $10,000 up 15 times to an eye-popping $160,000.
My Report Is Titled Grow Rich in This
'Medical Miracle' Super Stock -- And It's a
Treasure Trove of Money-Making Information
What I like best about the remarkable company revealed in my Report is its unending appetite for discovering new cures and aggressively pursuing them. It has research facilities in 49 countries and it's been in business for more than 128 years, selling in 142 countries around the world.
On its balance sheet, it has a cash balance of $4.3 billion dollars. And cash is pouring in at an eye-popping rate of around $150 million to $195 million per month. Yes, every month.
In this Report you'll discover...
- Exactly how high this stock can go. I'm basing my estimate on real-world, fundamental analysis. I can almost promise you that it can return more than you've ever made with any stock in the past...
- Precisely why this new remedy is so phenomenally potent...
- Why it's classified as a 'smart' drug. I'll give you a hint now on this blockbuster advantage: when the glucose begins to dangerously build up, this miracle worker snaps into action AUTOMATICALLY and brings it down. That's a historic breakthrough...
- The sales I'm projecting for this breakthrough? Hold onto your hat for this one. We're talking in the billions of dollars, with an enormously high profit margin...
A Subscriber Asked Me to Make a List of
My Favorite Stocks. I Did and I'll Send You Up to
5 Additional Reports at No Cost
My very favorite stock is this healthcare company. That's because its diabetes drug can become one of the biggest moneymakers ever. It's in your first free Report.
Get My FREE REPORT on This
'Miracle' Diabetes Enterprise
Get your free copy by clicking
the subscribe button at the
bottom of this letter.
'This stock can blow the
barn doors off any investment you've ever made.'
- Steven Lord
Editor, Steven Lord's Research Report |
|
When you join me as a subscriber, I'll send you this brand-new Report, Grow Rich In This 'Medical Miracle' Super Stock, absolutely free. But there's more to come.
Then I'll send you up to five additional free Reports on stocks -- for a total of six that I've exhaustively researched and can reliably deliver truly impressive profits.
Please remember, these aren't random 'stocks picks.' They're carefully researched enterprises with outstanding growth prospects. And they are in the most promising trends I know.
In a moment, I'd like to tell you more about my investing style and how it can help you achieve your financial objectives. But first, here's a description of the other five other stocks we're jumping into right now.
These 5 FREE REPORTS Zero in on the Most
Important Trends I See Today. They're the Best
Stocks in the Most Promising Industries
Your first FREE REPORT is the company involved in this extraordinary diabetes breakthrough: Grow Rich In This 'Medical Miracle' Super Stock. There are up to five additional Reports I have for you.
FREE REPORT #2:
300% Profits In America's
Least-Known Defense Dynamo
Here's another view toward protecting the American people. And I view this company as the premier player in this rapidly expanding field of highly sophisticated defense technology. This company develops, manufactures and supports a broad range of systems for critically important missions.
You name it, they're doing it: homeland security, Navy missile systems, weapons sensors, night vision equipment, infrared defense, laser aimers... They're so far ahead of the competition it's unbelievable.
They've been in business over 35 years, have sales for their last full fiscal year that exceed $1.7 billion -- and that's up 32% from 2005. In their most recent quarter in 2006, sales were a stone's throw away from $700 million. That's up a whopping 79%. Nothing can stop them because their market is BOOMING. Demand is only going up -- and fast!
FREE REPORT #3:
Outstanding Profits in This Outsourcing Giant
You've heard all that talk about outsourcing to India and China? There's a reason for it. The labor is cheap as heck and the quality of the work is superb. No one is cashing in more on this trend than a little-known $7-a-share enterprise I've found.
Sales in fiscal 2003 were just $1.1 million. In 2004, they went up to $29 million. In 2005, they soared to $44 million. And the first quarter in 2006 saw them rise to approximately $15 million -- that's up 62%. That's growth! Profits are also setting records.
They're one of the world's largest providers of call-center services and customer-relationship management services. What does that mean? Say you're Ford Motor and you're giving away a free booklet on your new truck via an 800-number. These are the folks that pick up the phone and get your name and address.
Customer-relationship management is similar. You buy a new Dell computer and you have questions on how something works. You pick up the phone and call these people, not Dell. As sales show, business is going through the roof!
Like it or hate it, this way of doing business is red hot. Their clients include Sony, American Express, Coco-Cola, Samsung, and many other blue-chip outfits. This one can hand you a very, very big gain with little, if any, risk.
FREE REPORT #4:
Huge Backdoor Profits From the Oil Boom
Here's a brilliant idea that turned into a billion-dollar empire. This fascinating enterprise provides engineering services and hardware to companies that operate in marine, space and other harsh environments. I think this stock can reward you with HUGE gains.
WebMD.com reveals:
'It's rising dramatically.'
|
|
Let's say that you're lucky enough to find oil in a part of the ocean that's known for very rough weather. These folks can help you get it out. And if a hurricane wrecks your equipment, they can help repair it.
Here's why this company is making a fortune: The 'easy' finds in oil are over. It's being found in some of the most rugged environments in the world. I'm talking about 40-foot waves and 75-mile-an-hour winds.
In 20 countries, they can build custom hardware, offer you rescue and repair services, expert personnel -- anything it takes to get the job done. Sales in 2003 were approximately $640 million.
Just two years later, they hit a cool billion with a net income of $62 million. In 2006, first-quarter earnings increased 140% to $25 million on sales of almost $290 million. This one is a slam-dunk in my mind.
OR...
Sign up for a two-year subscription to Steven Lord's Trend Investor for a discounted price and receive these 2 additional reports:
FREE REPORT #5:
Grand Slam Profits With This Wireless Wonder
Ever wonder how a big retail chain tracks and monitors 129,000 different inventory items in 2,300 stores? They have to know what's on hand, how many colors or other variations they have, where they are, how they're selling, when to reorder...
American Diabetes Association says 63 million people could die
|
|
It's a nightmare -- until now. I found a low-profile giant that's developed wireless data systems that lets customers identify, track and monitor anything that moves. They're incredible. Once this stock is 'discovered,' it could triple.
This gem has invented the world's most widely used bar code symbology. They provide supply-chain information to companies in hundreds of industries around the world.
And there's no substitute for their astonishingly effective systems. Sales for the first quarter of 2006 rose approximately 16% to $225 million, with earnings of $15 million -- up an impressive 179%.
FREE REPORT #6:
Triple Your Interest Income by Earning Safe,
Super Yields of 11% to 12%
This is one of the most interesting investments I've ever found. Here's your opportunity to collect a big fat yield of 11% to 12% -- or even more -- and have the potential for an eye-popping capital gain at the same time.
'After two years, I can finally reveal the name of this stock.'
- Steven Lord
Editor, Steven Lord's Trend Investor |
|
No, it's not some unknown corporation on the edge of closing its doors. I never invest in anything like that, nor do I recommend it. This is a major, multibillion-dollar manufacturing enterprise that hit some tough times. But when you look at the numbers the way I do, it's actually extremely interesting.
Its debt and preferred stock are tirelessly throwing off a river of cash, lining the pockets of smart investors. Why not yours? My free Report goes into detail and spells out how all this works in easy-to-understand terms.
Even if you put a small portion of your portfolio in these investments, you'd be absolutely amazed how this can boost your overall portfolio return.
I Truly Believe That With My Style of Investing, You
Can Be on Your Way to Building Real Wealth Faster
and With More Certainty Than Any Other Approach
I'm sure by now that you have a sense of what I look for in an investment. I'm cautious in that I view the protection of your capital being the first objective. But I also have developed proven criteria that allow me to capture enormous gains without taking senseless risks.
Over time, the market totally favors companies that are at the early stages of a major trend. This is one of the most risk-free ways of reliably building wealth starting with a modest sum of money.
That's because over time stock prices always follow the success of the basic business. Look at any of the biggest gainers. Without a single exception, what's behind them? A reliably profitable, fast-growing business.
I Never Get Trapped Into One Style
or Investment Category...
There are as many investing styles as there are investors. Most focus on a category that's too narrow or speculative for my taste. If you're committed to one industry, one method of analysis or one sector, you're going to lose out on the big ones that defy any category and sneak in under the radar. That's where the really big money is always made.
'Teva [Pharmaceuticals] rocketed from $4 to $45 -- up 10.2 Times. $10,000 grows to $112,000.'
|
|
I use elements of both value and growth investing in my analysis of the trends and in making forecasts. I check out balance sheet condition, the growth rate of sales, debt levels, cash on hand, debt-to-equity levels, return on equity, the price/earnings to growth -- also known as PEG -- goodwill valuations, the level of free cash flow, profit margins, profit growth and many other important criteria. I'm a big believer in buying a stock with very strong fundamentals.
Once my stock has passed these tests, the real work begins. What are the big ideas behind the stock? How does it fit into the needs of the evolving world we live in? What's the outlook for the trend?
This is where the real money is made. That's why I'm jumping in with both feet when it comes to my favorite stock that may alleviate the suffering caused by diabetes. To me, that's just common sense. One can make you rich... the other can make you well-off.
'It only takes one great stock to get rich. This one is it.'
- Steven Lord
Editor, Steven Lord's Trend Investor |
|
If I do my homework -- and I think two years of studying this stock proves I certainly do -- there's no reason why you can't have the opportunity to consistently earn life-changing gains if you act now.
I have every reason to believe this diabetes stock can do as well as any stock you've read about in this letter. And please remember how Wall Street loves healthcare. A few thousand dollars in the right healthcare stock can hand you a few hundred thousand, or more.
I Hope That You're Among the Exclusive
Group of Readers in This Powerhouse
That's because I believe this remarkable stock can do as well -- or even better -- than my previous selections. Nothing is as big as the wave of diabetes we face. That's why nine to 14 times your money is definitely a possibility.
'Sepracor shot up from $ to $65. That's up 15 times. $10,000 turned into $160,000.'
|
|
Here are a few of my past stock selections that remain open. The gain shown here represents the high the stock reached after I recommended it. You'll notice that they are in a wide variety of fields and company size.
- Corning: Up 1023%: You could have as much as 10 times your money on this one after I recommended it in November 2002. Corning was on the verge of a major turnaround.
- Advanced Micro: Up 561% : While other worried about its ability to compete with Intel, I recommended readers buy in because I was convinced they could grab a share of this booming market.
- Taseko: Up 383 %: This Canadian mining outfit is big in copper, gold, molybdenum and other vitally needed resources. It's a real leader.
- Rio Tinto: Up 98%% : They own a treasure trove of commodities that I felt was vastly undervalued.
- Core Laboratories: Up 125%%: This little-known gem supplies essential services to the oil and gas industry worldwide. Business soared.
- Evergreen Solar: Up 138%: This solar energy industry leader is helping us break the monopolistic grip of fossil fuels.
- Ladish: Up 103%: They make super strong forged metal casting -- the kind used in jet engines. It's a growth industry.
- Dr. Reddy's Labs: Up 113%: Few realize this India-based pharmaceutical giant that sells in 100 countries is such a powerhouse.
- BHP Billiton: Up 53%: All over the world these folks mine, drill and process minerals and other resources. Their record is spectacular.
Please Claim Your Free Reports
Now While Our Supply Lasts...
Let me rush you my just-off-the-press Report, Grow Rich In This 'Medical Miracle' Super Stock, PLUS up to five other free Reports. I couldn't be more enthusiastic about their prospects -- so you're joining at the right moment. It's your chance to make a profit that can change your life's plans.
Time magazine reveals:
Diabetes 'keeps on raging...'
|
|
I invite you to receive these free Reports by becoming a Charter Subscriber to my new publication, Steven Lord'sTrend Investor. I'm so sure you'll enjoy my new publication, I'll back that up with a remarkable guarantee.
If you decide in the first 90 days that that my publication doesn't live up to your highest expectations, please let me know by phone, e-mail or regular mail and I'll send you a full refund. All your free Reports are my thanks for giving it a try. Fair enough?
I Have Three Other FREE BONUSES
for You If You Act NOW...
I Have a Free Report On This Breakthrough Diabetes Stock.
Get your free copy by
subscribing to Steven Lord's
Trend Investor right now!
'Medtronic rose from $3.63 to $59 -- up 15.2 times. $10,000 rises to $162,000.' |
|
It doesn't stop with these six Reports. When you join me, I'll also give you a FREE subscription to Dynamic Market Alert, our daily e-letter that I write for. I also promise to give you weekly portfolio updates by e-mail. If anything changes, you'll instantly know about it.
Finally, we've spent countless months assembling the best financial site on the Internet. And you'll get free access to the all-important Member's section. And I back all this up.
The cost of a one-year (12-issues) subscription is 13 cents a day. That works out to $49 a year. And please take free Reports 1 - 4 as my thanks. A two-year (24-issues) subscription is just 12 cents a day, or $89 in total. Plus, I'll send you all six Reports.
I Hope This Is NOT Where We Part Ways...
There's Too Much at Stake
And after two years watching the facts unfold concerning my favorite stock that could cure diabetes, I can absolutely say that this stock should be in your portfolio.
To have a successful business a company must find a need and fill it. That's what they've done. It's one of the greatest needs known to mankind -- an unstoppable trend. I believe that life-changing wealth is at hand.
Rarely do opportunities like this one come along. Buying a great stock at a bargain price in a fast-growing market is the best and SAFEST way to get rich.
Let me leave you with this possibility: When this all hits The Wall Street Journal and you read about the fortune early investors made in this stock, you can't say, 'no one ever told me,' because I did in this letter.
This opportunity is absolutely extraordinary.
Please join me now by clicking the subscribe button at the bottom of this letter.
Welcome aboard!
Sincerely Yours,

Steven Lord
Editor, Trend Investor
P.S. Please don't delay. I can't guarantee that I'll contact you again. You have nothing to lose and EVERYTHING to gain -- you're protected by my eye-popping 90 day 100% refund guarantee. Join me right now.
P.P.S. Remember, by acting now, you'll ALSO receive three EXTRA free bonuses: a free subscription to my daily e-newsletter, plus, weekly portfolio updates and access to our jaw-dropping Web site. Don't delay...
Information as of: September 14, 2006

|